Copyright Reports & Markets. All rights reserved.

Global Tumor Biomarker Test Market Professional Survey Report 2018

Request for Sample of this report
Buy now

Table of Contents

    Global Tumor Biomarker Test Market Professional Survey Report 2017

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Tumor Biomarker Test Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Market Analysis by Types

      • 2.1 Overall Market Performance(Volume)
        • 2.1.1 Prostate Specific Antigen Tests Market Performance (Volume)
        • 2.1.2 CTC Tests Market Performance (Volume)
        • 2.1.3 Alpha-Fetoprotein (AFP) Tests Market Performance (Volume)
        • 2.1.4 CA Test Market Performance (Volume)
        • 2.1.5 HER2 Tests Market Performance (Volume)
      • 2.2 Overall Market Performance(Value)
        • 2.1.1 Prostate Specific Antigen Tests Market Performance (Value)
        • 2.1.2 CTC Tests Market Performance (Value)
        • 2.1.3 Alpha-Fetoprotein (AFP) Tests Market Performance (Value)
        • 2.1.4 CA Test Market Performance (Value)
        • 2.1.5 HER2 Tests Market Performance (Value)

      3 Product Application Market

      • 3.1 Overall Market Performance (Volume)
        • 3.1.1 Lung cancer Market Performance (Volume)
        • 3.1.2 Breast cancer Market Performance (Volume)
        • 3.1.3 Colorectal Market Performance (Volume)
        • 3.1.4 Prostate Cancer Market Performance (Volume)
        • 3.1.5 Blood Cancer Market Performance (Volume)

      4 Manufacturers Profiles/Analysis

      • 4.1 Abbott Laboratories, Inc.
        • 4.1.1 Abbott Laboratories, Inc. Profiles
        • 4.1.2 Abbott Laboratories, Inc. Product Information
        • 4.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Business Performance
        • 4.1.4 Abbott Laboratories, Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.2 Agilent Technologies
        • 4.2.1 Agilent Technologies Profiles
        • 4.2.2 Agilent Technologies Product Information
        • 4.2.3 Agilent Technologies Tumor Biomarker Test Business Performance
        • 4.2.4 Agilent Technologies Tumor Biomarker Test Business Development and Market Status
      • 4.3 AstraZeneca
        • 4.3.1 AstraZeneca Profiles
        • 4.3.2 AstraZeneca Product Information
        • 4.3.3 AstraZeneca Tumor Biomarker Test Business Performance
        • 4.3.4 AstraZeneca Tumor Biomarker Test Business Development and Market Status
      • 4.4 Becton Dickinson & Co.
        • 4.4.1 Becton Dickinson & Co. Profiles
        • 4.4.2 Becton Dickinson & Co. Product Information
        • 4.4.3 Becton Dickinson & Co. Tumor Biomarker Test Business Performance
        • 4.4.4 Becton Dickinson & Co. Tumor Biomarker Test Business Development and Market Status
      • 4.5 Biocept Inc.
        • 4.5.1 Biocept Inc. Profiles
        • 4.5.2 Biocept Inc. Product Information
        • 4.5.3 Biocept Inc. Tumor Biomarker Test Business Performance
        • 4.5.4 Biocept Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.6 Cancer Genetics Inc.
        • 4.6.1 Cancer Genetics Inc. Profiles
        • 4.6.2 Cancer Genetics Inc. Product Information
        • 4.6.3 Cancer Genetics Inc. Tumor Biomarker Test Business Performance
        • 4.6.4 Cancer Genetics Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.7 Danaher Corporation
        • 4.7.1 Danaher Corporation Profiles
        • 4.7.2 Danaher Corporation Product Information
        • 4.7.3 Danaher Corporation Tumor Biomarker Test Business Performance
        • 4.7.4 Danaher Corporation Tumor Biomarker Test Business Development and Market Status
      • 4.8 Foundation Medicine Inc.
        • 4.8.1 Foundation Medicine Inc. Profiles
        • 4.8.2 Foundation Medicine Inc. Product Information
        • 4.8.3 Foundation Medicine Inc. Tumor Biomarker Test Business Performance
        • 4.8.4 Foundation Medicine Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.9 Illumina Inc.
        • 4.9.1 Illumina Inc. Profiles
        • 4.9.2 Illumina Inc. Product Information
        • 4.9.3 Illumina Inc. Tumor Biomarker Test Business Performance
        • 4.9.4 Illumina Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.10 LabCorp Of America Holdings
        • 4.10.1 LabCorp Of America Holdings Profiles
        • 4.10.2 LabCorp Of America Holdings Product Information
        • 4.10.3 LabCorp Of America Holdings Tumor Biomarker Test Business Performance
        • 4.10.4 LabCorp Of America Holdings Tumor Biomarker Test Business Development and Market Status
      • 4.11 Luminex Corporation
      • 4.12 Myriad Genetics Inc.
      • 4.13 AstraZeneca

      5 Market Performance for Manufacturers

      • 5.1 Global Tumor Biomarker Test Capacity (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Tumor Biomarker Test Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Tumor Biomarker Test Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.4 Global Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 5.5 Global Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 5.6 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 China Market Performance for Manufacturers
        • 6.1.1 China Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 China Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 USA Market Performance for Manufacturers
        • 6.2.1 USA Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 USA Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 USA Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 USA Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Europe Market Performance for Manufacturers
        • 6.3.1 Europe Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Europe Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Europe Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Europe Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 Japan Market Performance for Manufacturers
        • 6.4.1 Japan Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 Japan Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 Japan Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 Japan Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Korea Market Performance for Manufacturers
        • 6.5.1 Korea Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Korea Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Korea Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Korea Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration
      • 6.6 India Market Performance for Manufacturers
        • 6.6.1 India Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.6.2 India Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.6.3 India Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.6.4 India Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.6.5 Market Concentration
      • 6.7 Southeast Asia Market Performance for Manufacturers
        • 6.7.1 Southeast Asia Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.7.2 Southeast Asia Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.7.3 Southeast Asia Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.7.4 Southeast Asia Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.7.5 Market Concentration
      • 6.8 South America Market Performance for Manufacturers
        • 6.8.1 South America Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.8.2 South America Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.8.3 South America Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.8.4 South America Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.8.5 Market Concentration

      7 Global Tumor Biomarker Test Market Performance (Sales Point)

      • 7.1 Global Tumor Biomarker Test Capacity (K Units) and Market Share by Regions 2013-2018
      • 7.2 Global Tumor Biomarker Test Sales (K Units) and Market Share by Regions 2013-2018
      • 7.3 Global Tumor Biomarker Test Revenue (M USD) and Market Share by Regions 2013-2018
      • 7.4 Global Tumor Biomarker Test Price (USD/Unit) by Regions 2013-2018
      • 7.5 Global Tumor Biomarker Test Gross Margin by Regions 2013-2018

      8 Development Trend for Regions (Sales Point)

      • 8.1 Global Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.2 China Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.3 USA Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.4 Europe Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.5 Japan Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.6 Korea Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.7 India Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.8 Southeast Asia Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.9 Southeast Asia Tumor Biomarker Test Capacity and Growth, Sales Value and Growth Rate2013-2018

      9 Development Trend for Regions (Sales Point)

      • 9.1 Global Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.2 China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.3 USA Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.4 Europe Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.5 Japan Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.6 Korea Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.7 India Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.8 Southeast Asia Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.9 South America Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018

      10 Upstream Source, Technology and Cost

      • 10.1 Upstream Source
      • 10.2 Technology
      • 10.3 Cost

      11 Channel Analysis

      • 11.1 Market Channel
      • 11.2 Distributors

      12 Consumer Analysis

      • 12.1 Lung cancer Industry
      • 12.2 Breast cancer Industry
      • 12.3 Colorectal Industry

      13 Market Forecast 2019-2024

      • 13.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
        • 13.1.1 Global Tumor Biomarker Test Capacity (K Units) and Share by Regions 2019-2024
        • 13.1.2 Global Tumor Biomarker Test Capacity (K Units), Sales (K Units) and Growth Rate 2019-2024
        • 13.1.3 China Tumor Biomarker Test Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.4 USA Tumor Biomarker Test Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.5 Europe Tumor Biomarker Test Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.6 Japan Tumor Biomarker Test Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.7 Korea Tumor Biomarker Test Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.8 India Tumor Biomarker Test Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.9 Southeast Asia Tumor Biomarker Test Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.10 South America Tumor Biomarker Test Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
        • 13.3.1 Overall Market Performance
        • 13.3.2 Prostate Specific Antigen Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.3 CTC Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.4 Alpha-Fetoprotein (AFP) Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.5 CA Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.4 Sales by Application 2019-2024
        • 13.4.1 Overall Market Performance
        • 13.4.2 Lung cancer Sales and and Growth Rate 2019-2024
        • 13.4.3 Breast cancer Sales and and Growth Rate 2019-2024
        • 13.4.4 Colorectal Sales and and Growth Rate 2019-2024
        • 13.4.5 Prostate Cancer Sales and and Growth Rate 2019-2024
      • 13.5 Price (USD/Unit) and Gross Profit
        • 13.5.1 Global Tumor Biomarker Test Price (USD/Unit) Trend 2019-2024
        • 13.5.2 Global Tumor Biomarker Test Gross Profit Trend 2019-2024

      14 Conclusion

      This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, covering
      Abbott Laboratories, Inc.
      Agilent Technologies
      AstraZeneca
      Becton Dickinson & Co.
      Biocept Inc.
      Cancer Genetics Inc.
      Danaher Corporation
      Foundation Medicine Inc.
      Illumina Inc.
      LabCorp Of America Holdings
      Luminex Corporation
      Myriad Genetics Inc.
      NanoString Technologies Inc.
      ...

      On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
      Prostate Specific Antigen Tests
      CTC Tests
      Alpha-Fetoprotein (AFP) Tests
      CA Test
      HER2 Tests
      BRCA Test
      Anaplastic Lymphoma Kinase (ALK) Tests
      EGFR Mutation Tests
      KRAS Test
      Others

      By Application, the market can be split into
      China
      USA
      Europe
      Japan
      Korea
      India
      Southeast Asia
      South America

      By Regions, this report covers (we can add the regions/countries as you want)

      If you have any special requirements, please let us know and we will offer you the report as you want.

      Buy now